Performance of Creatinine Clearance and Estimated GFR in Assessing Kidney Function in Living Donor Candidates.


Journal

Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144

Informations de publication

Date de publication:
03 2020
Historique:
pubmed: 18 6 2019
medline: 2 10 2020
entrez: 18 6 2019
Statut: ppublish

Résumé

Glomerular filtration rate (GFR) assessment is a key aspect in the evaluation of living kidney donor candidates; however, data on performance of commonly used methods are limited. We examined 769 living kidney donor candidates with 24-hour urine collections assessed as accurate by comparing measured creatinine excretion rate (CER) to CER estimated using a 4-variable equation previously developed and validated using robust methodology. Of all collections, 42.6% would have been deemed inaccurate, mostly under-collections, using the conventional weight- and gender-based CER estimation. Creatinine clearance (CrCl) overestimated I-iothalamate GFR (iGFR), estimated GFR (eGFR), underestimated iGFR, and their average [Avg (CrCl and eGFR)] essentially eliminated the GFR bias (median bias = +2.2, -5.4, and -1.0 mL/min/1.73 m, respectively; P < 0.001). This held true for all subgroups except blacks, where all 3 measures overestimated iGFR. Avg (CrCl and eGFR) also offered modestly improved accuracy compared with CrCl alone, as measured by the proportion of values falling within 10% (50.7% versus 45.3%; P = 0.009) and 30% of iGFR (94.5% versus 89.3%; P < 0.001). When measured GFR is unavailable, the Avg (CrCl and eGFR) provides a better estimate of kidney function in kidney donor candidates than either measure alone, although in blacks the estimates are neither better nor worse.

Sections du résumé

BACKGROUND
Glomerular filtration rate (GFR) assessment is a key aspect in the evaluation of living kidney donor candidates; however, data on performance of commonly used methods are limited.
METHODS
We examined 769 living kidney donor candidates with 24-hour urine collections assessed as accurate by comparing measured creatinine excretion rate (CER) to CER estimated using a 4-variable equation previously developed and validated using robust methodology.
RESULTS
Of all collections, 42.6% would have been deemed inaccurate, mostly under-collections, using the conventional weight- and gender-based CER estimation. Creatinine clearance (CrCl) overestimated I-iothalamate GFR (iGFR), estimated GFR (eGFR), underestimated iGFR, and their average [Avg (CrCl and eGFR)] essentially eliminated the GFR bias (median bias = +2.2, -5.4, and -1.0 mL/min/1.73 m, respectively; P < 0.001). This held true for all subgroups except blacks, where all 3 measures overestimated iGFR. Avg (CrCl and eGFR) also offered modestly improved accuracy compared with CrCl alone, as measured by the proportion of values falling within 10% (50.7% versus 45.3%; P = 0.009) and 30% of iGFR (94.5% versus 89.3%; P < 0.001).
CONCLUSIONS
When measured GFR is unavailable, the Avg (CrCl and eGFR) provides a better estimate of kidney function in kidney donor candidates than either measure alone, although in blacks the estimates are neither better nor worse.

Identifiants

pubmed: 31205262
doi: 10.1097/TP.0000000000002797
pii: 00007890-202003000-00025
doi:

Substances chimiques

Contrast Media 0
Iodine Radioisotopes 0
Iothalamic Acid 16CHD79MIX
Creatinine AYI8EX34EU
Iodine-125 GVO776611R

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

575-582

Références

Saran R, Robinson B, Abbott KC, et al. US renal data system 2018 annual data report: epidemiology of kidney disease in the United States.Am J Kidney Dis2019733S1A7–A8
Kasiske BL, Anderson-Haag T, Israni AK, et al. A prospective controlled study of living kidney donors: three-year follow-up.Am J Kidney Dis201566114–124
Muzaale AD, Massie AB, Wang MC, et al. Risk of end-stage renal disease following live kidney donation.JAMA2014311579–586
Mjøen G, Hallan S, Hartmann A, et al. Long-term risks for kidney donors.Kidney Int201486162–167
Grams ME, Sang Y, Levey AS, et al.; Chronic Kidney Disease Prognosis ConsortiumKidney-failure risk projection for the living kidney-donor candidate.N Engl J Med2016374411–421
Locke JE, Reed RD, Massie A, et al. Obesity increases the risk of end-stage renal disease among living kidney donors.Kidney Int201791699–703
OPTN (Organ Procurement and Transplantation Network)/UNOS (United Network for Organ Sharing)OPTN Policies, Policy 14: Living Donation.Available at http://optn.transplant.hrsa.gov/ContentDocuments/OPTN_Policies.pdf. Accessed November 3, 2017
Mandelbrot DA, Pavlakis M, Danovitch GM, et al. The medical evaluation of living kidney donors: a survey of US transplant centers.Am J Transplant200772333–2343
Walser M. Creatinine excretion as a measure of protein nutrition in adults of varying age.JPEN J Parenter Enteral Nutr1987115 Suppl73S–78S
Ix JH, Wassel CL, Stevens LA, et al. Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration.Clin J Am Soc Nephrol20116184–191
Levey AS, Stevens LA, Schmid CH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)A new equation to estimate glomerular filtration rate.Ann Intern Med2009150604–612
Israelit AH, Long DL, White MG, et al. Measurement of glomerular filtration rate utilizing a single subcutaneous injection of 125I-iothalamate.Kidney Int19734346–349
Efron B, Tibshirani R. Improvements on cross-validation: the 632+ bootstrap method.J Am Stat Assoc199792548–560
Issa N, Meyer KH, Arrigain S, et al. Evaluation of creatinine-based estimates of glomerular filtration rate in a large cohort of living kidney donors.Transplantation200886223–230
Huang N, Foster MC, Lentine KL, et al. Estimated GFR for living kidney donor evaluation.Am J Transplant201616171–180
Gaillard F, Flamant M, Lemoine S, et al. Estimated or measured GFR in living kidney donors work-up?Am J Transplant2016163024–3032
Inker LA, Schmid CH, Tighiouart H, et al.; CKD-EPI InvestigatorsEstimating glomerular filtration rate from serum creatinine and cystatin C.N Engl J Med201236720–29
Lentine KL, Kasiske BL, Levey AS, et al. Summary of kidney disease: improving global outcomes (KDIGO) clinical practice guideline on the evaluation and care of living kidney donors.Transplantation20171011783–1792
Lentine KL, Kasiske BL, Levey AS, et al. KDIGO clinical practice guideline on the evaluation and care of living kidney donors.Transplantation20171018S Suppl 1S1–S109
Nordén G, Lennerling A, Nyberg G. Low absolute glomerular filtration rate in the living kidney donor: a risk factor for graft loss.Transplantation2000701360–1362
Kher A, Mandelbrot DA. The living kidney donor evaluation: focus on renal issues.Clin J Am Soc Nephrol20127366–371
Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group.Ann Intern Med1999130461–470
Lewis J, Agodoa L, Cheek D, et al.; African-American Study of Hypertension and Kidney DiseaseComparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate.Am J Kidney Dis200138744–753

Auteurs

Neetika Garg (N)

Division of Nephrology, University of Wisconsin School of Medicine and Public Health, Madison, WI.

Grace Snyder (G)

Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Jianbo Li (J)

Qualitative Health Sciences, Cleveland Clinic, Cleveland, OH.

Didier Mandelbrot (D)

Division of Nephrology, University of Wisconsin School of Medicine and Public Health, Madison, WI.

Emilio D Poggio (ED)

Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH